Atreo Reaches 100th Study Milestone as Modern RTSM

Atreo is officially celebrating a fantastic milestone, by launching its 100th clinical trial study.

Reflecting on a journey that began just just under four years ago, Atreo's leadership team expressed deep gratitude to the early adopters who trusted the platform with pivotal Phase 3 trials when the company only had a handful of systems live. In an industry traditionally bogged down by rigid legacy systems, choosing an unproven partner was a bold move by industry pioneers. Today, that trust has translated into a rapid footprint expansion across the clinical trial ecosystem.

Why Clinical Teams Are Shifting to Modern RTSM Providers

The fundamental challenge in the Randomization and Trial Supply Management (RTSM) industry has long been operational friction. Legacy software remains heavily resource-reliant, making it incredibly difficult for clinical teams to execute rush First Patient In (FPI) timelines or deploy critical system changes within short timeframes.

Atreo was built specifically to solve these technology bottlenecks. By stripping away legacy complexities, the platform enables clinical sponsors to hit high-pressure milestones efficiently, often prompting unprompted, rewarding feedback from clients who finally experience agile trial management.

Innovation Driven by Technology and Teamwork

While cutting-edge technology handles the heavy lifting, Atreo attributes the 100th study milestone to the collaborative efforts of its global team. Delivering seamless clinical trial support requires cross-functional excellence across product engineering, project management, and quality testing groups.

As Atreo looks ahead to the next milestones, rapidly scaling toward 200, 300, and 400 studies, every software release continues to expand what can be achieved within compressed timelines. The company remains dedicated to pushing the boundaries of innovation and maintaining its trajectory as a leader in clinical trial agility.

Discover how our agile platform can accelerate your next protocol by exploring our modern RTSM platform features.